Compliance Corner: Here’s How Stryker Decides Whether To Launch A Device Recall
Stryker Corp. regulatory expert Ommeed Shahrokh explains the device giant’s decision-making process around product recalls and describes what’s included in recall letters to customers.
You may also be interested in...
From cutting costs to getting products to market faster, experts at the two companies explain why it pays to keep quality at the fore.
The US agency said on 26 May that the Dragonfly OpStar imaging catheter was recalled by the company because of troubles with the device’s marker band.
Longtime industry experts Kim Trautman, Steve Niedelman and Dennis Gucciardo spoke with Medtech Insight about interesting or insightful stakeholder comments on the US FDA’s proposed Quality Management System Regulation. Part one of two.